Nanoviricides (NNVC) Share-based Compensation (2014 - 2026)
Nanoviricides' Share-based Compensation came in at $38,252 for fiscal Q4 2026 (quarter ended Jun 30, 2026), unchanged from $38,250 a year earlier and down 32.0% from the prior quarter.
Nanoviricides (NNVC) Share-based Compensation (2014 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Nanoviricides' Share-based Compensation was $317,833, up 95.4% from FY2025.
- Share-based Compensation carries a five-year compound annual growth rate of 12.1% (FY2021 to FY2026).
- Going back by fiscal year, Share-based Compensation was $162,625 in FY2025 (-9.1%), $178,940 in FY2024 (+13.4%), $157,822 in FY2023 (-22.3%) and $203,018 in FY2022 (+13.2%).
- The five-year range for quarterly Share-based Compensation is $38,250 (fiscal Q1 2023) to $185,100 (fiscal Q2 2026).
- Year-over-year, Share-based Compensation increased in two of the last eight quarters, with growth averaging 47.5%.
- The fastest year-over-year change in Share-based Compensation over five years came in fiscal Q2 2026 (growth of 383.9%), and the weakest in fiscal Q4 2023 (a decline of 48.3%).
- Business Quant data shows NNVC's Share-based Compensation at $56,231 (Q3 2026), $185,100 (Q2 2026) and $38,250 (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Nanoviricides | 28.47 Mn | 16.13 Mn | - | 38,252.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38,252.00 |
| Mar 31, 2026 | 56,231.00 |
| Dec 31, 2025 | 185,100.00 |
| Sep 30, 2025 | 38,250.00 |
| Jun 30, 2025 | 38,250.00 |
| Mar 31, 2025 | 40,375.00 |
| Dec 31, 2024 | 38,250.00 |
| Sep 30, 2024 | 45,750.00 |
| Jun 30, 2024 | 38,250.00 |
| Mar 31, 2024 | 40,590.00 |
| Dec 31, 2023 | 38,250.00 |
| Sep 30, 2023 | 61,850.00 |
| Jun 30, 2023 | 38,250.00 |
| Mar 31, 2023 | 43,072.00 |
| Dec 31, 2022 | 38,250.00 |
| Sep 30, 2022 | 38,250.00 |
| Jun 30, 2022 | 74,000.00 |
| Mar 31, 2022 | 45,018.00 |
| Dec 31, 2021 | 42,000.00 |
| Sep 30, 2021 | 42,000.00 |
Nanoviricides Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NNVC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();